NEW YORK, May 10, 2026 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Gartner, Inc. (NYSE: IT) between February 4, 2025 and February 2, 2026, both dates inclusive (the “Class Period”), of the important May 18, 2026 lead plaintiff
Juan Pepa and Felipe Morenés-Botín, Co-Founders and Managing Partners of Stoneshield Capital LUXEMBOURG, May 07, 2026 (GLOBE NEWSWIRE) — Stoneshield Capital is the second-largest shareholder in Meliá Hotels International (“Meliá”) with a 9.5% stake, and Juan Pepa, co-founder of Stoneshield, has been appointed to Meliá’s Board of Directors. The appointment
Why Holafly for Business is becoming the preferred choice for global companies DUBLIN, May 04, 2026 (GLOBE NEWSWIRE) — For IT teams, one of the biggest risks when an employee travels is not the flight itself, but what happens upon arrival: landing without reliable internet access. This goes far beyond
Nyxoah to Participate in the Bank of America 2026 Healthcare Conference Mont-Saint-Guibert, Belgium – April 30, 2026, 10:05 pm CET / 4:05 pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive
The pioneer of alcohol-free spirits, creator of the revolutionary W.A.R.M. Molecule™, is now inviting entrepreneurs worldwide to join the future of celebration. ARKAY products are alcohol-free, Halal-friendly, and do not require a liquor license for mocktail bar operations OUTDOOR ARKAY MOCKTAIL BAR GARDEN ARKAY MOCKTAIL BAR MIAMI, April 30, 2026
LEPAS presents its vision of “Driving Elegance Together,” blending refined design, intelligent technology, and an elevated lifestyle experience.[/caption] WUHU, China, April 29, 2026 (GLOBE NEWSWIRE) — From April 26 to 28, 2026, LEPAS, the NEV brand under Chery Group, hosted its first Global Partner Conference in Wuhu under the theme
Nyxoah to Release First Quarter 2026 Financial Results on May 12, 2026 Mont-Saint-Guibert, Belgium – April 28, 2026, 10:05pm CET / 4:05pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), that develops breakthrough treatment alternatives for Obstructive Sleep Apnea (OSA) through neuromodulation, today announced that the Company
Nyxoah to Release First Quarter 2026 Financial Results on May 12, 2026 Mont-Saint-Guibert, Belgium – April 28, 2026, 10:05pm CET / 4:05pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), that develops breakthrough treatment alternatives for Obstructive Sleep Apnea (OSA) through neuromodulation, today announced that the Company